0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-905.36%PremiumJan 17, 2025Expiry Date6.75Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Precigen Stock Discussion
Precigen Receives Orphan Drug Designation For PRGN-2012 For Treatment Of Recurrent Respiratory Papillomatosis From The European Commission
$Advanced Micro Devices (AMD.US)$ $Aridis Pharmaceuticals (ARDS.US)$ $Alarum Technologies (ALAR.US)$ $180 Life Sciences (ATNF.US)$ $First Wave BioPharma (FWBI.US)$ $IBM Corp (IBM.US)$ $MasterCard (MA.US)$ $Microsoft (MSFT.US)$ $Mullen Automotive (MULN.US)$ $Novo Integrated Sciences (NVOS.US)$ $Ocuphire Pharma (OCUP.US)$ $Precigen (PGEN.US)$ $Tesla (TSLA.US)$ $Minerva Surgical (UTRS.US)$
In reaction to earnings/guidance:
• $Deutsche Bank (DB.US)$ +5.6%, $Salesforce (CRM.US)$ +2.3%, $H.B. Fuller (FUL.US)$ +2.2%, $Trip.com (TCOM.US)$ +0.7%
Other news:
• $Precigen (PGEN.US)$ +3.9% (names new COO)
• $Scorpio Tankers (STNG.US)$ +2.7% (reports it purchased its common shares in the open market and exercised a purchase option for an LR2 product tanker that is currently leased)
• $Marinus Pharmaceuticals (MRNS.US)$ +1.6% (...
No comment yet